NYSEAMERICAN:VNRX traded up $0.05 on Friday, hitting $2.29. 40,500 shares of the company’s stock traded hands, compared to its average volume of 105,591. VolitionRX has a 1 year low of $1.44 and a 1 year high of $4.00.
VolitionRX (NYSEAMERICAN:VNRX) last released its earnings results on Wednesday, November 7th. The medical research company reported ($0.14) earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.14).
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
Recommended Story: NASDAQ
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.